About this trial
A Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema
Eligibility criteria
Qualifiers
Signed Informed Consent
Diagnosis of COPD/emphysema
At least 22-years of age
18 ≤ BMI ≤ 32
Disqualifiers
Currently participating in another clinical study that involves surgery, interventional or pharmaceutical treatment
α-1 Antitrypsin deficiency
Women of child-bearing potential
More than 2 COPD exacerbation episodes requiring hospitalization in the last year prior to screening
Trial design
Treatments tested in this trial
- Implantable pulmonary stent
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov